Taylor CJ - Search Results

1

Gastrointestinal outcomes and confounders in cystic fibrosis.

Borowitz D, Durie PR, Clarke LL, Werlin SL, Taylor CJ, Semler J, De Lisle RC, Lewindon P, Lichtman SM, Sinaasappel M, Baker RD, Baker SS, Verkade HJ, Lowe ME, Stallings VA, Janghorbani M, Butler R, Heubi J. Borowitz D, et al. Among authors: taylor cj. J Pediatr Gastroenterol Nutr. 2005 Sep;41(3):273-85. doi: 10.1097/01.mpg.0000178439.64675.8d. J Pediatr Gastroenterol Nutr. 2005. PMID: 16131979 Review. No abstract available.

2

ESPGHAN and NASPGHAN Report on the Assessment of Exocrine Pancreatic Function and Pancreatitis in Children.

Taylor CJ, Chen K, Horvath K, Hughes D, Lowe ME, Mehta D, Orabi AI, Screws J, Thomson M, Van Biervliet S, Verkade HJ, Husain SZ, Wilschanski M. Taylor CJ, et al. J Pediatr Gastroenterol Nutr. 2015 Jul;61(1):144-53. doi: 10.1097/MPG.0000000000000830. J Pediatr Gastroenterol Nutr. 2015. PMID: 25915425

3

Genetic modifiers of liver disease in cystic fibrosis.

Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group. Bartlett JR, et al. Among authors: taylor cj. JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295. JAMA. 2009. PMID: 19738092 Free PMC article.

4

Cystic fibrosis: terminology and diagnostic algorithms.

De Boeck K, Wilschanski M, Castellani C, Taylor C, Cuppens H, Dodge J, Sinaasappel M; Diagnostic Working Group. De Boeck K, et al. Thorax. 2006 Jul;61(7):627-35. doi: 10.1136/thx.2005.043539. Epub 2005 Dec 29. Thorax. 2006. PMID: 16384879 Free PMC article. Review.

5

Modifier genes and cystic fibrosis liver disease.

Pirzada O, Taylor C. Pirzada O, et al. Hepatology. 2003 Mar;37(3):714; author reply 714. doi: 10.1053/jhep.2003.50079. Hepatology. 2003. PMID: 12601371 No abstract available.

6

Hyperhomocystinemia in children with inflammatory bowel disease.

Nakano E, Taylor CJ, Chada L, McGaw J, Powers HJ. Nakano E, et al. Among authors: taylor cj. J Pediatr Gastroenterol Nutr. 2003 Nov;37(5):586-90. doi: 10.1097/00005176-200311000-00016. J Pediatr Gastroenterol Nutr. 2003. PMID: 14581802

7

Renal effects of glibenclamide in cystic fibrosis mice.

Kibble J, Neal A, White S, Green R, Evans S, Taylor C. Kibble J, et al. J Am Soc Nephrol. 2001 Nov;12(11):2507-2510. doi: 10.1681/ASN.V12112507. J Am Soc Nephrol. 2001. PMID: 11675429

8

Guidelines for the diagnosis and management of distal intestinal obstruction syndrome in cystic fibrosis patients.

Colombo C, Ellemunter H, Houwen R, Munck A, Taylor C, Wilschanski M; ECFS. Colombo C, et al. J Cyst Fibros. 2011 Jun;10 Suppl 2:S24-8. doi: 10.1016/S1569-1993(11)60005-2. J Cyst Fibros. 2011. PMID: 21658638 Free article. Review.

9

Systematic review of the dry powder inhalers colistimethate sodium and tobramycin in cystic fibrosis.

Uttley L, Harnan S, Cantrell A, Taylor C, Walshaw M, Brownlee K, Tappenden P. Uttley L, et al. Eur Respir Rev. 2013 Dec;22(130):476-86. doi: 10.1183/09059180.00001513. Eur Respir Rev. 2013. PMID: 24293463 Free PMC article. Review.

10

Quantitative analysis of regional airways obstruction using dynamic hyperpolarized 3He MRI-preliminary results in children with cystic fibrosis.

Koumellis P, van Beek EJ, Woodhouse N, Fichele S, Swift AJ, Paley MN, Hill C, Taylor CJ, Wild JM. Koumellis P, et al. Among authors: taylor cj. J Magn Reson Imaging. 2005 Sep;22(3):420-6. doi: 10.1002/jmri.20402. J Magn Reson Imaging. 2005. PMID: 16104046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

532 results

Search Page